Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronic acid for prevention of AI-associated arthralgias
NCT03384095Phase 2Withdrawn
- Start
- Dec 2018
- Primary completion
- Dec 2018
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of hyaluronic acid in arthralgia. Planned start Dec 2018; status: withdrawn.
02
Drugs
hyaluronic acid
03
Conditions
arthralgia
Beyond the preview
Go deeper on NCT03384095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03384095.